Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of I-124 PET/CT to I-123 Whole Body Imaging for the Diagnosis of Thyroid
NCT06961084Phase 2Recruiting
- Start
- Dec 2025
- Primary completion
- Apr 2028
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of Iodine-124 in thyroid cancer. Started Dec 2025; status: recruiting.
02
Drugs
Iodine-124
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT06961084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06961084.